| Revista: | International braz j urol |
| Base de datos: | PERIÓDICA |
| Número de sistema: | 000434657 |
| ISSN: | 1677-5538 |
| Autores: | Balaban, Muhsin1 Ozkaptan, Orkunt2 Sevinc, Cuneyd3 Boz, Mustafa Yucel4 Horuz, Rahim4 Kafkasli, Alper2 Canguven, Onder5 |
| Instituciones: | 1Biruni University, School of Medicine, Estambul. Turquía 2Kartal Training and Research Hospital, Department of Urology, Estambul. Turquía 3Istinye University, School of Medicine, Estambul. Turquía 4Medipol University, School of Medicine, Estambul. Turquía 5Hamad Medical Corporation, Department of Urology, Doha City. Qatar |
| Año: | 2020 |
| Periodo: | Ene-Feb |
| Volumen: | 46 |
| Número: | 1 |
| País: | Brasil |
| Idioma: | Inglés |
| Tipo de documento: | Artículo |
| Enfoque: | Analítico, descriptivo |
| Resumen en inglés | Objectives: To investigate the characteristics of cases of NIH category I acute prostatitis developed after transrectal prostate biopsy and clarifiy the risk factors and preventive factors. Materials and Methods: We retrospectively reviewed the medical records of 3.479 cases of transrectal ultrasound-guided needle biopsies performed with different prophylactic antibiotherapy regimens at two different institutions between January 2011 and February 2016. The patients of Group I have received ciprofl oxacin (n=1.523, 500mg twice daily) and the patients of Group II have received ciprofl oxacin plus ornidazole (n=1.956, 500mg twice daily) and cleansing enema combination as prophylactic antibiotherapy. The incidence, clinical features and other related microbiological and clinical data, were evaluated. Results: Mean age was 62.38±7.30 (47-75), and the mean prostate volume was 43.17±15.20 (21-100) mL. Of the 3.479 patients, 39 (1.1%) developed acute prostatitis after the prostate biopsy procedure. Of the 39 cases of acute prostatitis, 28/3.042 occurred after the first biopsy and 11/437 occurred after repeat biopsy (p=0.038). In Group I, 22 of 1.523 (1.4%) patients developed acute prostatitis. In Group II, 17 of 1.959 (0.8%) patients developed acute prostatitis. There was no statistical difference between the two groups according to acute prostatitis rates (X2=2.56, P=0.11). Further, hypertension or DM were not related to the development of acute prostatitis (P=0.76, X2=0.096 and P=0.83, X2=0.046, respectively). Conclusions: Repeat biopsy seems to increase the risk of acute prostatitis, while the use of antibiotics effective for anaerobic pathogens seems not to be essential yet |
| Disciplinas: | Medicina |
| Palabras clave: | Urología, Cirugía, Próstata, Biopsia, Profilaxis, Ciprofloxacina, Prostatitis |
| Keyword: | Urology, Surgery, Prophylaxis, Ciprofloxacin, Prostatitis, Prostate, Biopsy |
| Texto completo: | Texto completo (Ver HTML) Texto completo (Ver PDF) |
